Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteins by interferon in a human hepatocarcinoma cell line (PLC/PRF/5)

Journal of Hepatology

Volumn 25, Issue 1, 1996, Pages 15-19

  Berthillon, Pascale ^a   Crance, Jean Marc ^b   Leveque, Françoise ^b   Jouan, Alain ^b   Petit, Marie Anne ^a   Deloince, Robert ^b   Trepo, Christian ^a  

^a INSERM   (France)

^b U de Biol Molec   (France)

Author keywords

Cell culture; Hepatitis A virus; Hepatitis B virus; Interferon; Liver cancer

Indexed keywords

INTERFERON; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CANCER RISK; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

EID: 0030198597     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80322-9     Document Type: Article

References (19)

1. Joussemet M, Bourin P, Buisson Y, Fabre G. Diminution du taux de prévalence des anticorps anti-VHA chez les jeunes militaires de 20 ans. Bull Epidemiol Hebdo. 28:1991;115-116.
2. Forbes A, Williams R. Changing epidemiology and clinical aspects of hepatitis A. Br Med Bull. 46:1990;303-318.
3. Hadler SC. Global impact of hepatitis A infection changing patterns. Holliger FB, Lemon SM, Margolis H. Viral Hepatitis: A Liver Disease. 1991;14-20 Williams and Wilkins, Baltimore.
4. Kani JIA, Nandwani R, Gilson RJL, Johnson AM, Maguire HC, Tedder RS. Hepatitis A virus infection among homosexual men (letter). Br Med J. 302:1991;1399.
5. Evangelos A, Akriviadis EA, Redeker AG. Fulminant hepatitis A in intravenous drug users with chronic liver disease. Ann Intern Med. 110:1989;838.
6. Gimson AE, White YS, Eddleston AL, Williams R. Clinical and prognostic differences in fulminant hepatitis type A, B and non-A non-B. Gut. 24:1983;1194.
7. Shih SM, Jo S, Miyamura T, Chen SY, Wu Lee YH. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HUH-7 cells. J Virol. 67:1993;5823-5832.
8. Alexander JJ, Bey EM, Geddes EW, Lecatsas G. Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J. 50:1976;2124-2128.
9. Crance JM, Passagot J, Verwaerde N, Biziagos E, Gandre H, Deloince R. Adaptation à la lignée cellulaire PLC/PRF/5 du virus de l'hépatite A libéré dans le surnageant de culture. CR Acad Sci Paris. 301:1985;361-363.
10. Petit MA, Zoulim F, Capel F, Dublanchet S, Dauguet C, Trepo C. Variable expression of pre S1 antigen in serum during chronic hepatitis B virus (HBV) infection: an accurate marker for the level of HBV replication. Hepatology. 11:1990;809-814.
11. Crance JM, Passagot J, Biziagos E, Deloince R. Continuous production of hepatitis A virus in PLC/PRF/5 cell cultures: use of antigen for serology. J Virol Methods. 18:1985;193-203.
12. Crance JM, Biziagos E, Passagot J, Van Cuyck-Gandre H, Deloince R. Inhibition of hepatitis A replication in vitro by antiviral compounds. J Med Virol. 31:1990;155-160.
13. Hayashi Y, Koike K. Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA. J Virol. 1989;2936-2940.
14. Caselmann WH, Meyer M, Scholz S, Hofschneider PH, Koshy R. Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells. J Infect Dis. 166:1992;966-971.
15. Foster GR, Ackrill AM, Goldin RD, Kerr IM, Thomas HC, Stark OR. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons α and γ and double-stranded RNA. Proc Natl Sci USA. 88:1991;2888-2892.
16. Oon CJ. Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of lymphoblastoid α interferon in the prophylaxis of high risk precancerous conditions. Cancer Chemother Pharmacol. 31:1992;S137-S142. (suppl).
17. Gauss-Müller V, Deinhardt F. Effect of hepatitis A virus infection on cell metabolism in vitro. Proc Soc Exp Biol Med. 175:1984;10-15.
18. Yoshiba M, Inoue K, Sekiyama K. Interferon for hepatitis A. Lancet. 343:1994;288-289.
19. Keefe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol. 90:1995;201-205.